Published in J Clin Pathol on July 01, 1971
Prevalence of hepatitis B antigen and antibody in prostitutes. Br Med J (1974) 1.66
Hepatitis B antigen in prostitutes. Br J Vener Dis (1974) 0.94
An approach to VD control based on a study in Kingston, Jamaica. Br J Vener Dis (1974) 0.91
Viral hepatitis related antigens in 'autoimmune' hepatic disorders. Can Med Assoc J (1972) 0.89
Sterilization of instruments and serum hepatitis. Proc R Soc Med (1974) 0.78
Prevalence of Hepatitis B surface antigen in dental personnel. J Oral Maxillofac Pathol (2015) 0.75
The ultrastructure of Australia antigen in the presence and the absence of specific antibodies. Br J Exp Pathol (1973) 0.75
Technique of complementfixation test applicable to the diagnosis of virus diseases. Mon Bull Minist Health Public Health Lab Serv (1962) 17.29
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 11.61
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
Rapid detection of Australia antigen by counterimmunoelectrophoresis. J Immunol (1970) 6.51
Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA (1967) 6.36
Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature (1968) 6.34
A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA (1965) 6.21
Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81
Immune complexes in hepatitis. Lancet (1969) 4.33
Association between polyarteritis and Australia antigen. Lancet (1970) 4.32
Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med (1968) 4.28
Relation of Australia-SH antigen to the willowbrook MS-2 strain. N Engl J Med (1969) 4.13
Hepatitis antigen. Correlation with disease and infectivity of blood-donors. Lancet (1969) 4.03
Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science (1970) 4.00
Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science (1969) 3.98
An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med (1969) 3.54
S.H. antigen in haemodialysis-associated hepatitis. Lancet (1969) 2.85
Australia antigen in acute and chronic liver disease. Lancet (1969) 2.65
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Observations on Australia antigen in Japanese. Vox Sang (1968) 2.57
Biophysical properties of Australia antigen. J Virol (1969) 2.45
Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders. Lancet (1970) 2.38
Viral hepatitis. A staff hazard in dialysis units. Lancet (1967) 2.38
Persistence of the serum hepatitis (SH-Australia) antigen for many years. Nature (1969) 2.37
Additional specificities of Australia antigen and the possible identification of hepatitis carriers. Nature (1969) 2.28
Further studies on a "new" human isoprecipitin system (Australia antigen). Blood (1966) 2.16
Immunologic distinction between infectious and serum hepatitis. N Engl J Med (1970) 2.16
Studies of Australia-SH antigen in sporadic viral hepatitis in London. Br Med J (1970) 2.13
Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet (1970) 2.11
Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technic. Nature (1969) 1.97
Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA (1968) 1.94
Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A (1969) 1.84
Hepatitis-associated antigen in chronic liver disease. Lancet (1969) 1.82
Virus-like particles in sera of patients with infectious and serum hepatitis. JAMA (1969) 1.68
RNA of Australia antigen. Nat New Biol (1971) 1.60
Faecal S.H. (Australia) antigen in acute hepatitis. Lancet (1971) 1.60
Complement fixation and immunodiffusion tests for assay of hepatitis-associated "Australia" antigen and antibodies. J Immunol (1970) 1.54
Australia antigen (a hepatitis-associated antigen): purification and physical properties. J Exp Med (1970) 1.46
Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. J Infect Dis (1970) 1.45
Prevalence of serum-hepatitis-related antigen (SH) in different geographic regions. Am J Trop Med Hyg (1970) 1.42
Cirrhosis associated with the Australia antigen in an infant who acquired hepatitis from her mother. Br Med J (1970) 1.29
Presence and persistence of Australia antigen among drug addicts. Vox Sang (1971) 1.26
Some antigenic and physical properties of virus-like particles in sera of hepatitis patients. J Immunol (1969) 1.25
Failure to detect an antigen associated with hepatitis in a community epidemic. Nature (1970) 1.16
Rapid detection of Australia antigen by cross-over electrophoresis. Lancet (1970) 1.14
Production of antibody against "Australia antigen" in rabbits. Nature (1966) 1.14
Detection of a new serum-antigen in three epidemics of short-incubation hepatitis. Lancet (1970) 1.12
Double diffusion in agarose: precipitin lines which are not the result of antigen--antigody reactions. Immunology (1969) 1.07
Electron microscopical and immunological observations on the serum-hepatitis (S.H.) antigen in primary biliary cirrhosis. Lancet (1970) 1.07
Australia antigen in chronic hepatitis in Australia. Br Med J (1970) 1.07
Hepatitis-associated antigen (Australia antigen) in mother and infant. N Engl J Med (1970) 1.04
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 1.03
Evaluation of frequency of Australia antigen in blood donors of Tokyo by means of immune adherence hemagglutination technique. Vox Sang (1971) 0.99
The production of antibodies to Australia antigen in mouse ascites fluid. Proc Soc Exp Biol Med (1970) 0.95
Failure of transplacental transmission of Australia antigen. Lancet (1969) 0.94
Acute infective hepatitis. Fine structural and cytochemical alterations in human liver. Arch Pathol (1968) 0.92
Radioimmunoassay of Australia antigen. Vox Sang (1971) 0.90
Detection of Au(1) antigen by immunodiffusion and platelet aggregation tests. Vox Sang (1971) 0.90
Viral hepatitis associated with illicit parenteral use of drugs. JAMA (1968) 0.90
Australia antigen serology in the Holy Cross football team hepatitis outbreak. Lancet (1970) 0.86
New immunologic relationships of Australia antigen. Vox Sang (1971) 0.84
Study of the Australia antigen and of the corresponding antibody in blood donors in Paris. Vox Sang (1971) 0.82
Morphology and immunological properties of Australia-SH antigen in hepatitis. Microbios (1971) 0.81
A study of the incidence of Australia antigen and antibody in nonhuman primates. Vox Sang (1971) 0.78
Australia antigen in various plasma fractions. Vox Sang (1971) 0.77
The age distribution of hepatitis-associated antigen (HAA) in Switzerland. Vox Sang (1971) 0.77
Membrane-complement fixation test for hepatitis associated antigen. Nature (1970) 0.76
Hepatitis in a haemodialysis unit. Lancet (1969) 0.76
Parvovirus-like particles in human sera. Lancet (1975) 7.11
Post-transfusion hepatitis revisited. Med J Aust (1995) 2.46
Studies of Australia-SH antigen in sporadic viral hepatitis in London. Br Med J (1970) 2.13
Application of a screening test for antibody the hepatitis B core antigen. J Clin Pathol (1977) 1.85
Evolution of poliovirus since introduction of attenuated vaccine. Br Med J (1977) 1.82
Needlestick injury in medical students. Med J Aust (1994) 1.68
Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study. Lancet (1982) 1.66
Tuberculosis: medical students at risk. Med J Aust (1994) 1.43
Epidemiology of serum hepatitis. Br Med Bull (1972) 1.33
Genetic marker studies of poliovirus. I. Natural variation. J Hyg (Lond) (1967) 1.30
Detection of persistent vegetative bacteria and amplified viral nucleic acid from in-use testing of gastrointestinal endoscopes. J Hosp Infect (1998) 1.28
Hepatitis in dialysis units in the United Kingdom. Br Med J (1972) 1.23
Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology (1987) 1.14
Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14
Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. Gastroenterology (1988) 1.06
User's guide to some new tests for hepatitis-B antigen. Lancet (1974) 1.05
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 1.03
Impact of rubella vaccination in Australia. Lancet (1984) 0.98
Latex test for AU antigen. Lancet (1972) 0.97
Australia antigen and the human fetus. Am J Dis Child (1972) 0.93
Human papillomavirus: the untreated male reservoir. J Urol (1988) 0.92
Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol (1997) 0.91
An enzyme-linked immunosorbent-assay test for hepatitis B surface antigen. J Clin Pathol (1977) 0.91
Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity. Epidemiol Infect (1991) 0.91
Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia. J Clin Microbiol (2001) 0.90
Natural duck hepatitis B virus infection in Australia. Aust J Exp Biol Med Sci (1986) 0.90
Delta associated hepatitis in Australia. Aust N Z J Med (1983) 0.90
Papillomavirus and cervical cancer: a clinical and laboratory study. J Med Virol (1988) 0.90
Genetic marker studies of poliovirus. II. Strains isolated from cases of poliomyelitis associated with the administration of live attenuated vaccine. J Hyg (Lond) (1967) 0.89
Experimental duck hepatitis B virus infection: pathology and evolution of hepatic and extrahepatic infection. Hepatology (1988) 0.89
The current pattern of hepatitis B virus infection in Australia. J Viral Hepat (2006) 0.88
Specificity of Au antibodies. Lancet (1971) 0.88
False-negative radioimmunoassay tests for Australia antigen. Lancet (1973) 0.88
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg (1998) 0.88
What determines the incidence of serum hepatitis after blood transfusion? Am J Dis Child (1972) 0.88
Marker studies of poliovirus. Nature (1966) 0.88
Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol (1997) 0.87
Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men. Genitourin Med (1991) 0.87
Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer (2000) 0.86
Prevalence and distribution of human papillomavirus type-16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormality. Int J Cancer (1992) 0.85
Horizontal transmission of hepatitis B in a children's day-care centre: a preventable event. Aust N Z J Public Health (1997) 0.84
Detection of specific types of human papillomavirus in cervical scrapes, anal scrapes, and anogenital biopsies by DNA hybridization. J Med Virol (1987) 0.83
Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction. Gynecol Oncol (1995) 0.82
False-positive results with hepatitis B virus DNA dot-hybridization in hepatitis B surface antigen-negative specimens. J Clin Microbiol (1986) 0.82
Australia antigen and hepatitis in renal units. Proc Eur Dial Transplant Assoc (1972) 0.82
Molecular epidemiology and variation of hepatitis B in recent immigrant families to Australia. J Med Virol (1998) 0.81
Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol (2000) 0.81
Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18. Am J Obstet Gynecol (1995) 0.81
Detection of HPV DNA in archival specimens of cervical cancer using in situ hybridisation and the polymerase chain reaction. J Med Virol (1992) 0.81
Morphology and immunological properties of Australia-SH antigen in hepatitis. Microbios (1971) 0.81
The outcome of hepatitis B virus infection in pregnancy. Postgrad Med J (1977) 0.81
Hepatitis antigen. Lancet (1969) 0.81
Detection of human papillomavirus type 16 E6/E7 transcripts in fixed paraffin-embedded cervical cancers by the polymerase chain reaction. J Virol Methods (1991) 0.80
Inactivation of duck hepatitis B virus by a hydrogen peroxide gas plasma sterilization system: laboratory and 'in use' testing. J Hosp Infect (1999) 0.80
Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model. J Vasc Surg (1999) 0.79
The clinical management and laboratory assessment of anal warts. Med J Aust (1987) 0.78
Optimised growth of human epidermal cells in vitro without the use of a feeder layer or collagen substrate. Aust J Exp Biol Med Sci (1985) 0.78
Clinical and virological associations between external anogenital warts and cervical HPV infection in an STD clinic population. Int J STD AIDS (1991) 0.78
Papillomavirus DNA and prognosis in cervical cancer. Lancet (1991) 0.77
Anal intercourse: a risk factor for anal papillomavirus infection in women? Genitourin Med (1991) 0.76
Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model. J Hosp Infect (1996) 0.76
Hepatitis delta virus in homosexual men in Sydney. Genitourin Med (1989) 0.76
Acquisition of hepatitis B antigen in the newborn period. Postgrad Med J (1974) 0.75
Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet (1994) 0.75
Serum hepatitis as a persistent infection. J Clin Pathol Suppl (R Coll Pathol) (1972) 0.75
Rapid method for the concentration of hepatitis B virus particles using Beckman airfuge. J Clin Pathol (1986) 0.75
Transplantation of cultured autologous epidermis to a patient with burns. Med J Aust (1987) 0.75
Risk of hepatitis C virus infection in multiply transfused premature neonates. J Paediatr Child Health (2001) 0.75
Molecular evidence of transmission of hepatitis B in a day-care centre. Lancet (1996) 0.75
Detection of human papillomavirus DNA on surgeons' gloves: possible implications for patients with cervical cancer. Int J Cancer (1995) 0.75
The core of the matter. Int J Artif Organs (1981) 0.75
A novel human papillomavirus DNA sequence related to epidermodysplasia verruciformis-associated types isolated from recurrent scar carcinoma. Arch Dermatol (1999) 0.75
Immunity in Pekin ducks experimentally and naturally infected with duck hepatitis B virus. J Med Virol (1989) 0.75
Australia antigen and hepatitis,. Public Health (1974) 0.75
Some data about Australia antigen (HAA) in Great Britain. Vox Sang (1971) 0.75
Adolescence: a second risk period of hepatitis B transmission in immigrant families resident in Australia? Med J Aust (1996) 0.75
Transmission of hepatitis B from mother to infant. Med J Aust (1978) 0.75
What is Australia antigen? Am J Dis Child (1972) 0.75
Relationship between hepatitis B virus DNA in blood and serological markers of hepatitis B infection. Med J Aust (1986) 0.75
Varicella vaccination of health-care workers. Vaccine (1999) 0.75
Epidermal cell populations and antigen expression in cultures of human neonatal epidermis. Aust J Exp Biol Med Sci (1986) 0.75
Genetic marker studies on poliovirus type 1 strains from the Blackburn poliomyelitis outbreak in 1965. J Hyg (Lond) (1968) 0.75
Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers. Aust N Z J Surg (2000) 0.75
The relation between electrophoretic mobility and serological subtype of HBSAg. Bibl Haematol (1976) 0.75
An autopsy survey of hepatitis B in Sydney. Pathology (1995) 0.75
Cell biology of cultured anogenital warts. Br J Dermatol (1987) 0.75
Postexposure treatment of experimental DHBV infection: a new therapeutic strategy. J Med Virol (1990) 0.75
Detection of human papillomavirus type 16 E6/E7 transcripts in histologically cancer-free pelvic lymph nodes of patients with cervical carcinoma. Gynecol Oncol (1994) 0.75
Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer. Gynecol Oncol (1995) 0.75
Low-dose intradermal vaccination of medical and dental students. Med J Aust (1990) 0.75
A new particulate antigen present in serum. Dev Biol Stand (1975) 0.75